IL265252A - Stable pharmaceutical foam - Google Patents

Stable pharmaceutical foam

Info

Publication number
IL265252A
IL265252A IL265252A IL26525219A IL265252A IL 265252 A IL265252 A IL 265252A IL 265252 A IL265252 A IL 265252A IL 26525219 A IL26525219 A IL 26525219A IL 265252 A IL265252 A IL 265252A
Authority
IL
Israel
Prior art keywords
stable pharmaceutical
pharmaceutical foam
foam
stable
pharmaceutical
Prior art date
Application number
IL265252A
Other languages
Hebrew (he)
Other versions
IL265252B1 (en
IL265252B2 (en
Original Assignee
Omrix Biopharmaceuticals Ltd
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL247810A external-priority patent/IL247810A0/en
Application filed by Omrix Biopharmaceuticals Ltd, Ethicon Inc filed Critical Omrix Biopharmaceuticals Ltd
Publication of IL265252A publication Critical patent/IL265252A/en
Publication of IL265252B1 publication Critical patent/IL265252B1/en
Publication of IL265252B2 publication Critical patent/IL265252B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IL265252A 2016-09-14 2017-09-11 Stable pharmaceutical foam IL265252B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662394371P 2016-09-14 2016-09-14
IL247810A IL247810A0 (en) 2016-09-14 2016-09-14 Stable pharmaceutical foam
PCT/IL2017/000007 WO2018051325A1 (en) 2016-09-14 2017-09-11 Stable pharmaceutical foam

Publications (3)

Publication Number Publication Date
IL265252A true IL265252A (en) 2019-05-30
IL265252B1 IL265252B1 (en) 2023-07-01
IL265252B2 IL265252B2 (en) 2023-11-01

Family

ID=60022140

Family Applications (1)

Application Number Title Priority Date Filing Date
IL265252A IL265252B2 (en) 2016-09-14 2017-09-11 Stable pharmaceutical foam

Country Status (9)

Country Link
EP (1) EP3512502A1 (en)
JP (1) JP7114597B2 (en)
KR (1) KR102656742B1 (en)
CN (1) CN109789091A (en)
AU (1) AU2017328480A1 (en)
CA (1) CA3036770A1 (en)
IL (1) IL265252B2 (en)
MA (1) MA46239A (en)
WO (1) WO2018051325A1 (en)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2492458A (en) 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
CH264752A (en) * 1947-06-03 1949-10-31 Hoffmann La Roche Process for the manufacture of carriers for pharmaceuticals.
JPS5814813B2 (en) * 1976-11-09 1983-03-22 味の素株式会社 Foaming agent and its manufacturing method
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
JP5133482B2 (en) 1999-07-21 2013-01-30 イムデ ビオマテリオー Adhesive protein foam for surgical and / or therapeutic use, and methods and kits for its production
JP2003523409A (en) 2000-02-25 2003-08-05 デイビッド シエラ Foam-forming wound dressing
JP4113781B2 (en) 2001-03-26 2008-07-09 バイエル アクチェンゲゼルシャフト Melt polymerized polycarbonate with outstanding "shear fluidization characteristics"
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US6749842B2 (en) * 2002-01-24 2004-06-15 Midwest Grain Products Liquid foam builder containing hydrolyzed grain protein
US8202549B2 (en) 2007-08-14 2012-06-19 The Regents Of The University Of California Mesocellular oxide foams as hemostatic compositions and methods of use
CA2710798A1 (en) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
CN102014973A (en) * 2008-02-29 2011-04-13 弗罗桑医疗设备公司 Device for promotion of hemostasis and/or wound healing
KR101541702B1 (en) * 2008-03-03 2015-08-04 옴릭스 바이오파머슈티컬스 리미티드 A gelatin sponge comprising an active ingredient, its preparation and use
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US20110036133A1 (en) * 2008-04-18 2011-02-17 N. V. Organon Purification of protein hydrolysate and the result and products
US20100021527A1 (en) 2008-07-25 2010-01-28 Chunlin Yang Collagen-related peptides and uses thereof and hemostatic foam substrates
US8778883B2 (en) 2009-11-13 2014-07-15 Industrial Technology Research Institute Foamy biomaterial for biological tissue repair
RU2013155713A (en) * 2011-07-06 2015-08-20 Профибрикс Бв COMPOSITIONS FOR TREATMENT OF THE RAS
US8680240B1 (en) 2012-11-01 2014-03-25 George David Falus Tissue sealant for use in non-compressible hemorrhage
US10307509B2 (en) 2012-12-07 2019-06-04 Baxter International Inc. Hemostatic foam
CN105543315A (en) * 2015-12-16 2016-05-04 陕西科技大学 Collagen foaming agent, compound modified collagen foaming agent and their preparation methods

Also Published As

Publication number Publication date
KR102656742B1 (en) 2024-04-15
JP2019526646A (en) 2019-09-19
MA46239A (en) 2019-07-24
CN109789091A (en) 2019-05-21
CA3036770A1 (en) 2018-03-22
KR20190054110A (en) 2019-05-21
IL265252B1 (en) 2023-07-01
IL265252B2 (en) 2023-11-01
JP7114597B2 (en) 2022-08-08
AU2017328480A1 (en) 2019-03-14
WO2018051325A1 (en) 2018-03-22
EP3512502A1 (en) 2019-07-24

Similar Documents

Publication Publication Date Title
HK1254343A1 (en) Pharmaceutical formulations
ZA201903101B (en) Pharmaceutical formulations
ZA201900019B (en) Pharmaceutical combinations
PT3426294T (en) Pharmaceutical formulation
IL262745A (en) Improved drug formulations
GB201603949D0 (en) Foam dispensers
GB201509828D0 (en) Foam dispensers
IL248775A0 (en) Foam for pulmonary drug delivery
IL269239A (en) Pharmaceutical combination comprising ponesimod
IL253177A0 (en) Pharmaceutical formulation
HK1245653A1 (en) Pharmaceutical formulation
IL254794A0 (en) Pharmaceutical formulations
IL266537A (en) Pharmaceutical formulation
ZA201807851B (en) Pharmaceutical formulation
IL250160A0 (en) Pharmaceutical agent
GB201521175D0 (en) Frustule Foams
GB201511246D0 (en) Pharmaceutical formulation
GB201417589D0 (en) Pharmaceutical Formulations
IL265252A (en) Stable pharmaceutical foam
IL247810A0 (en) Stable pharmaceutical foam
PL3463676T3 (en) Foam dispenser
GB201616767D0 (en) New pharmaceutical use
GB201611917D0 (en) Pharmaceutical agents
GB201611916D0 (en) Pharmaceutical agents
GB201610440D0 (en) Pharmaceutical formulations